Journal article · 2012
Cognitive Remediation in the Early Course of Schizophrenia: A Critical Review
Current Pharmaceutical Design, 18(4), 534–541 · Published 1 February 2012 · DOI 10.2174/138161212799316091
In brief
“Cognitive Remediation in the Early Course of Schizophrenia: A Critical Review” is a 2012 journal article by Stefano Barlati and 4 co-authors, published in Current Pharmaceutical Design. OpenAlex counts 43 citations as of 20 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 43
- Most cited in
- 2022 (5)
- Field-weighted impact
- 3.14
- References
- 55
- Authors
- 5
Abstract
BACKGROUND: The aim of cognitive remediation is to target the cognitive impairments of patients with psychosis, including attentional deficits, memory problems, and limitations in planning and problem solving. It is hoped that by addressing these deficits, patients will be more able to take advantage of other interventions and will be more able to function in… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Barlati, S., De Peri, L. M., Deste, G., Fusar‐Poli, P., & Vita, A. (2012). Cognitive Remediation in the Early Course of Schizophrenia: A Critical Review. Current Pharmaceutical Design, 18(4), 534–541. https://doi.org/10.2174/138161212799316091
MLA 9
Barlati, Stefano, et al. “Cognitive Remediation in the Early Course of Schizophrenia: A Critical Review.” Current Pharmaceutical Design, vol. 18, no. 4, 2012, pp. 534–541. https://doi.org/10.2174/138161212799316091.
Chicago
Barlati, Stefano, Luca Mario De Peri, Giacomo Deste, Paolo Fusar‐Poli, and Antonio Vita. 2012. “Cognitive Remediation in the Early Course of Schizophrenia: A Critical Review.” Current Pharmaceutical Design 18 (4): 534–541. https://doi.org/10.2174/138161212799316091.
Harvard
Barlati, S. et al. (2012) ‘Cognitive Remediation in the Early Course of Schizophrenia: A Critical Review’, Current Pharmaceutical Design, 18(4), pp. 534–541. doi:10.2174/138161212799316091.
IEEE
S. Barlati, L. M. De Peri, G. Deste, P. Fusar‐Poli, and A. Vita, “Cognitive Remediation in the Early Course of Schizophrenia: A Critical Review,” Current Pharmaceutical Design, vol. 18, no. 4, pp. 534–541, 2012, doi: 10.2174/138161212799316091.
BibTeX
@article{barlati2012cognitive,
title = {{Cognitive Remediation in the Early Course of Schizophrenia: A Critical Review}},
author = {Barlati, Stefano and De Peri, Luca Mario and Deste, Giacomo and Fusar‐Poli, Paolo and Vita, Antonio},
journal = {Current Pharmaceutical Design},
year = {2012},
volume = {18},
number = {4},
pages = {534--541},
doi = {10.2174/138161212799316091},
url = {https://doi.org/10.2174/138161212799316091}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2017 | 2 | |
| 2018 | 2 | |
| 2019 | 2 | |
| 2020 | 3 | |
| 2021 | 1 | |
| 2022 | 5 | |
| 2023 | 1 | |
| 2024 | 3 | |
| 2025 | 1 | |
| 2026 | 1 |
Its field-weighted citation impact is 3.14: it has been cited 3.14 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- cognitive remediation
- schizophrenia
- prodromal symptoms
- cognitive training
- cognitive impairment
- attention deficits
- memory impairment
- functional recovery
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Barlati, S., De Peri, L. M., Deste, G., Fusar‐Poli, P., & Vita, A. (2012). Cognitive Remediation in the Early Course of Schizophrenia: A Critical Review. Current Pharmaceutical Design, 18(4), 534–541. https://doi.org/10.2174/138161212799316091
How many times has this paper been cited?
43 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Stefano Barlati, Luca Mario De Peri, Giacomo Deste, Paolo Fusar‐Poli, Antonio Vita.
What is the DOI of this paper?
10.2174/138161212799316091, permanently at https://doi.org/10.2174/138161212799316091. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.